Lv1
46 积分 2021-12-21 加入
Prostate cancer
9小时前
待确认
Bispezifische Antikörper in der Therapie des Prostatakarzinoms
9小时前
待确认
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes
9小时前
已完结
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
9小时前
已完结
Prostate cancer treatment – China's perspective
9小时前
已完结
Prostate cancer
15天前
已完结
Abstract 5821: DXC008, a novel STEAP1 antibody-tubulysin analog conjugate with a function linker, demonstrates a potential to broaden therapeutic opportunities for prostate tumors
16天前
已关闭
Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding
21天前
已完结
A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer
26天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
30天前
已完结
皖公网安备34019202002308
